Am J Transplant, Volume 18, Suppl 3 Archives - ATC Abstracts

2018 American Transplant Congress
Donor Hypothermia Outcomes in Living Kidney Transplantation
J. Buggs,¹ J. Wei,² E. Rogers,³ R. Liu,² V. Bowers.¹
¹Transplant Surgery, Tampa General Medical Group, Tampa General Hospital, Tampa, FL; ²Molecular Pharmacology and Physiology, University of South Florida Morsani College of Medicine, Tampa, FL; ³Transplant Research, Tampa General Hospital, Tampa, FL.
Background: The effect of donor hypothermia is known to significantly reduce the rate of delayed graft function (DGF) in cadaveric donor kidney transplantation. The effect…
2018 American Transplant Congress
Improved Renal Allograft Survival for Pre-Emptive Paediatric Renal Transplant Recipients in the United Kingdom
M. Marlais,¹ K. Martin,² S. Marks.¹
¹Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; ²NHS Blood and Transplant, Bristol, United Kingdom.
OBJECTIVESThe aim of this study was to investigate whether being on dialysis at the time of renal transplantation affected renal allograft survival in paediatric renal…
2018 American Transplant Congress
Impact of Pre-Transplant Dialysis on ESRD-Free and Patient Survival in Heart Transplant Alone and in Simultaneous Heart/Kidney Transplant Recipients: UNOS Data Analysis
S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.
Medicine, Loyola University, Maywood, IL.
It is well known that chronic kidney disease has significant negative impact on post-transplant survival in heart transplant (HTx) recipients. Here we wanted to evaluate…
2018 American Transplant Congress
A Protocol for the Management of Alemtuzumab Induced Leukopenia in Kidney Transplant Recipients
S. Hammad, B. Ravichandran, M. Crist, B. Masters.
University of Maryland Medical Center, Baltimore.
Purpose: Leukopenia is a common complication following alemtuzumab induction in kidney transplant recipients (KTR), often limiting its use. Our institution developed a protocol to manage…
2018 American Transplant Congress
Burden of Infectious Complications after Upper Extremity Allotransplantation: A Matched Cohort Study
A. Conrad,^1,2,3 P. Petruzzo,^4,5 J. Kanitakis,⁶ A. Gazarian,⁷ L. Badet,^3,8 P. Vanhems,^3,9 O. Thaunat,^1,3,10 E. Morelon,^1,3,10 A. Sicard.^1,3
¹Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon (HCL), Lyon, France; ²Department of Infectious Diseases and Tropical Medicine, HCL, Lyon, France; ³Claude Bernard Lyon 1 University, Lyon, France; ⁴Department of Transplantation, HCL, Lyon, France; ⁵Department of Surgery, University of Cagliari, Cagliari, Italy; ⁶Department of Dermatology, HCL, Lyon, France; ⁷Clinique du Parc, Lyon, France; ⁸Department of Urology and Transplantation, HCL, Lyon, France; ⁹Infection Control and Epidemiology Unit, HCL, Lyon, France; ¹⁰INSERM U1111, International Center for Infectiology Research, Lyon, France.
This study aimed to assess the infectious risk after upper extremity allotransplantation (UEA), a non-vital transplantation procedure requiring lifelong immunosuppression. A matched cohort study was…
2018 American Transplant Congress
Solid Organ Transplantation and Data Mining: Risk Factors for Invasive Fungal Disease in Heart Transplant Recipients
N. Barros, D. Xie, C. Yek, T. Liu, X. Li, B. Adams-Huet, J. Martinez, S. Garg, J. Grodin, R. Morelend, A. Amin, F. Aras, J. Thibodeau, P. Mammen, M. Peltz, M. Drazner, W. Ring, R. Haley, R. La Hoz.
UT Southwestern, Dallas, TX.
We created a database of solid organ transplant (SOT) recipients using innovative data mining tools. This study describing the epidemiology of invasive fungal disease (IFD)…
2018 American Transplant Congress
Detection of Different Gene Expression Profiles in CD8⁺ T Cells from Chronic High EBV Load Carriers after Pediatric Heart and Liver Transplantation
M. Yamada,^1,2 C. Macedo,² X. Gu,² M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 U. Chandran,³ B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.^1,2
¹Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; ²Thomas E. Starzl Transplantation Institute, Pittsburgh, PA; ³Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA.
Background: EBV infection and post-transplant lymphoproliferative disorders (PTLD) are life-threatening complications of pediatric solid organ transplantation (Tx). The risk for PTLD varies by transplanted organ,…
2018 American Transplant Congress
Containment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections at a Solid Organ Transplant Centre
A. Mularoni,¹ G. Martucci,¹ S. Gruttadauria,¹ M. Campanella,¹ F. Tuzzolino,¹ G. Arena,¹ A. Arcadipane,¹ U. Palazzo,¹ A. Luca,¹ B. Gridelli,¹ P. Grossi.²
¹ISMETT-IRCCS, Palermo, Italy; ²University of Insubria, Varese, Italy.
Objectives The aim is to describe epidemiology and analyze the effectiveness of the intervention in CRE containment in SOT patients (pts).Methods In 2012 a taskforce…
2018 American Transplant Congress
Linking Donor Ischemia Reperfusion Injury (IRI) to Costimulatory Blockade Resistant Murine Heart Graft Rejection through Complement-Initiated Necroptosis
R. Ang, N. Chun, A. Ting, P. Heeger.
Immunology Institute, Translational Transplant Research, Icahn School of Medicine at Mount Sinai, New York, NY.
We previously showed that prolonged cold ischemic storage (CIS) of donor B6 hearts results in complement dependent, CTLA4Ig-resistant rejection in BALB/c recipients. In this system,…
2018 American Transplant Congress
How Safe is Crossing the ABO Blood Group Barrier? A Meta-Analysis to Determine the Additive Risk of ABO-Incompatible Kidney Transplantation
A. de Weerd, M. Betjes.
Nephrology and Kidney Transplantation, Erasmus Medical Center, Rotterdam, Netherlands.
Background ABO blood group-incompatible (ABOi) kidney transplantation is considered a safe procedure, with non-inferior outcomes in large cohort studies. Its contribution to living kidney transplantation…

1
2
3
…
211
Next Page »